Agilent Technologies (A)

NYSE Health Care Life Sciences Tools & Services S&P 500
$174.76
+2.98 (+1.73%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W-0.1%
1M+3.9%
3M+17.5%
6M+51.1%
YTD+28.4%
1Y+19.1%
3Y+69.9%
5Y+11.0%

Key statistics

Full financials →
Market cap$49.3B
P/E (TTM)34.5
EPS (TTM, diluted)$5.07
P/S6.68
P/B6.69
EV / EBITDA26.9
Revenue (TTM)$7.37B
Revenue growth+8.6%
Net margin19.5%
ROE19.6%
Debt / equity0.54
FCF yield2.6%
Dividend yield0.58%
Payout ratio20%
Beta (1Y)0.89
Volatility (1Y)32.1%
52-week range$108.35 – $182.99
Avg volume (50D)2.30M

Revenue & net income — last 8 quarters

Statements →

Filing briefs

All 15 A briefs →
Sep 8, 8:15 AM ET

Agilent Chair Boon Hwee Koh Retires; Glenn Boehnlein Joins Board

Neutral leadership Written later 5.027.01

Agilent's board chair, Boon Hwee Koh, retired from the board effective September 4, 2026, after more than two decades of service. The board appointed former Stryker CFO Glenn Boehnlein as a director the same day and elected director Dow R. Wilson as chair. The changes are board governance updates with no financial results disclosed in the filing.

  • Koh retired effective September 4, 2026, citing no disagreement with the company or board; he had served on the board since 2003 and as independent chair since 2017.
  • Glenn Boehnlein was appointed a Class III director effective September 4, 2026, and joins the Audit and Finance and Compensation committees.
  • Boehnlein was Vice President and CFO of Stryker Corporation from 2016 to 2025; the board determined he is an audit committee financial expert.
  • Dow R. Wilson, a director since 2018 who chairs the Audit and Finance Committee, was elected board chair effective September 4, 2026.
Read the filing on SEC.gov ↗
Aug 26, 4:06 PM ET

Agilent Q3 revenue rises 8.1% to $1.88 billion; fiscal 2026 outlook raised

Positive earnings Written later 2.02

Agilent reported third-quarter fiscal 2026 revenue of $1.88 billion for the quarter ended July 31, 2026, up 8.1% from a year earlier, with GAAP EPS of $1.28 versus $1.18. The company raised its fiscal 2026 non-GAAP EPS guidance to $6.18 to $6.21 and its revenue guidance to $7.49 billion to $7.51 billion, so both headline results and forward expectations moved higher for shareholders.

  • Q3 revenue was $1.88 billion, up 8.1% reported and 7.3% core; GAAP net income was $362 million, or $1.28 per share.
  • Non-GAAP EPS was $1.62, up 18% from the year-ago quarter, including a $0.06 net benefit from tariff refunds.
  • Fiscal 2026 non-GAAP EPS is now expected at $6.18 to $6.21, an increase of 15 cents at the midpoint.
  • Fourth-quarter 2026 revenue is expected at $1.98 billion to $2.0 billion, with non-GAAP EPS of $1.71 to $1.74 and no future tariff refund benefit assumed.
Read the filing on SEC.gov ↗
Jun 25, 4:23 PM ET

Agilent sells $600 million of 4.900% senior notes due 2032

Neutral financing Written later 1.012.03

Agilent Technologies closed a $600 million private placement of 4.900% senior notes maturing January 15, 2032, sold at 99.968% of principal. The notes are senior unsecured obligations that are not guaranteed by subsidiaries, and the filing adds a registration rights agreement that could raise the interest rate if the company does not complete a registered exchange offer.

  • Principal amount of $600 million; issued at 99.968% of principal amount
  • Fixed rate of 4.900% per annum, paid semi-annually on January 15 and July 15, starting January 15, 2027
  • Maturity date January 15, 2032; redeemable before December 15, 2031 at the greater of par or a make-whole price
  • Exchange offer targeted by June 25, 2027; additional interest of 0.25% per annum per 90-day period, capped at 0.50%
Read the filing on SEC.gov ↗
May 27, 4:06 PM ET

Agilent raises FY26 EPS guidance as Q2 revenue rises 10% to $1.83 billion

Positive earnings Written later 2.025.02

Agilent reported second-quarter fiscal 2026 results with revenue of $1.83 billion, up 10.0% from a year earlier, and GAAP net income of $339 million, up from $215 million. The company raised its fiscal 2026 non-GAAP EPS guidance to $6.00 to $6.10, which matters to shareholders because it signals higher expected per-share earnings for the year. The filing also discloses a new Chief Accounting Officer, Tim Downs, replacing Rodney Gonsalves, who is retiring.

  • Q2 revenue of $1.83 billion, up 10.0% reported and 6.3% core, for the quarter ended April 30, 2026
  • GAAP EPS of $1.20 versus $0.75 a year earlier; non-GAAP EPS of $1.49 versus $1.31
  • Fiscal 2026 non-GAAP EPS guidance raised to $6.00 to $6.10, an increase of 8 cents at the midpoint; fiscal Q3 non-GAAP EPS expected at $1.48 to $1.50
  • Tim Downs appointed Vice President, Chief Accounting Officer on May 20, 2026, effective after the Form 10-Q filing; Rodney Gonsalves retires
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Recent SEC filings

EDGAR ↗

Famous investors who own A

All investors →
InvestorValue% of portfolioLast quarter
Ray Dalio Bridgewater Associates $3.04M0.01% Reduced

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All A congressional trades →
TradedMemberTypeAmount
Sep 23, 2025Julie Johnson TX-32Sell$1,001 – $15,000
Sep 23, 2025Julie Johnson TX-32Buy$1,001 – $15,000
Jul 16, 2025Lisa McClain MI-09Sell$1,001 – $15,000
Jun 17, 2025Lisa McClain MI-09Buy$1,001 – $15,000
May 12, 2025Jefferson Shreve IN-06Sell$15,001 – $50,000
May 15, 2025Rob Bresnahan PA-08Buy$1,001 – $15,000
Apr 01, 2025Julie Johnson TX-32Sell (partial)$1,001 – $15,000
Apr 17, 2025Jefferson Shreve IN-06Buy$15,001 – $50,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Prices are end-of-day and split-adjusted. Financial data from Agilent Technologies's SEC XBRL filings. Not investment advice.